Literature DB >> 17950050

A fully automated system for inorganic antimony preconcentration and speciation in urine.

Pablo H Pacheco1, Raúl A Gil, Luis D Martinez, Griselda Polla, Patricia Smichowski.   

Abstract

A study was undertaken to ascertain the analytical capabilities of L-methionine immobilized on controlled pore glass for Sb preconcentration and speciation. A fully automated on-line system, implemented with hydride generation (HG) and inductively coupled plasma optical emission spectrometry (ICP OES), was used. Sb(III), at pH 10 was selectively retained in the column containing the immobilized aminoacid, while Sb(V) was not retained at all. A 30% HCl solution was used as eluent agent. Prior to total Sb determination, a pre-reduction step with thiourea was necessary. An on-line pH adjusting and pre-reduction of Sb(V) was achieved in a fully automated system. The detection limit for the preconcentration of 10 mL of an aqueous solution was 70 ng L(-1) with a relative standard deviation of 2%. An enrichment factor of 20 was achieved when 10 mL of sample was passed through the system, reaching a throughput of 23 samples per hour. The method was successfully applied to the determination of Sb(III) and total Sb in urine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950050     DOI: 10.1016/j.aca.2007.09.034

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  3 in total

1.  The potential DNA toxic changes among workers exposed to antimony trioxide.

Authors:  Safaa El Shanawany; Nermine Foda; Doaa I Hashad; Naglaa Salama; Zahraa Sobh
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-30       Impact factor: 4.223

Review 2.  Application of hyphenated techniques in speciation analysis of arsenic, antimony, and thallium.

Authors:  Rajmund Michalski; Sebastian Szopa; Magdalena Jabłońska; Aleksandra Łyko
Journal:  ScientificWorldJournal       Date:  2012-05-02

3.  Antimonene with two-orders-of-magnitude improved stability for high-performance cancer theranostics.

Authors:  Guihong Lu; Chengliang Lv; Weier Bao; Feng Li; Fan Zhang; Lijun Zhang; Shuang Wang; Xiaoyong Gao; Dongxu Zhao; Wei Wei; Hai-Yan Xie
Journal:  Chem Sci       Date:  2019-04-02       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.